CELL THERAPEUTICS INC 4
4 · CELL THERAPEUTICS INC · Filed Mar 26, 2007
Insider Transaction Report
Form 4
STROMATT SCOTT
EVP, Clinical Dev & Reg Affair
Transactions
- Award
Incentive Stock Option (right to buy)
2007-01-18+60,000→ 60,000 totalExercise: $1.70Exp: 2017-01-18→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The reporting of this transaction is late due to an administrative oversight.
- [F2]This option vests as follows: 25% shall become exercisable on 1/18/2008, and equal amounts of the remaining 75% shall become exercisable each month for the next three years thereafter.